Haemodynamic effects of levosimendan in advanced but stable chronic heart failure
Clicks: 252
ID: 272406
2018
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
6.0
/100
20 views
20 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Levosimendan was associated with improved haemodynamics in patients with stable chronic HF, but we could not identify any predictors of the magnitude of haemodynamic response.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (25 words).
Try re-searching for a better abstract.
| Reference Key |
e2018eschaemodynamic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Najjar E;Stålhberg M;Hage C;Ottenblad E;Manouras A;Haugen Löfman I;Lund LH;; |
| Journal | ESC heart failure |
| Year | 2018 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
research support
non-u.s. gov't
female
male
middle aged
Prospective Studies
Randomized Controlled Trial
follow-up studies
dose-response relationship
drug
intravenous
infusions
hemodynamics / drug effects
heart failure / drug therapy*
cardiotonic agents / administration & dosage
heart failure / physiopathology
pmid:29469177
pmc5933961
doi:10.1002/ehf2.12272
emil najjar
marcus stålhberg
lars h lund
hemodynamics / ethics*
simendan / administration & dosage*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.